Lv4
760 积分 2025-07-06 加入
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity
13天前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
1个月前
已完结
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
2个月前
已完结
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2个月前
已完结
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
2个月前
已完结
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity
2个月前
已完结
Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
2个月前
已完结
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
2个月前
已完结
Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis
2个月前
已完结
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
2个月前
已完结
皖公网安备34019202002308
